Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 7, 2025 • 6:00 AM ET

Date/Time Source News Release
05/28/2025 01:30 AM EDT GlobeNewswire InflaRx Announces Outcome of Interim Analysis for Vilobelimab Phase 3 Trial in Pyoderma Gangrenosum
05/22/2025 07:30 AM EDT GlobeNewswire InflaRx to Participate in Upcoming Investor Conferences
05/07/2025 07:30 AM EDT GlobeNewswire InflaRx Reports First Quarter 2025 Financial Results and Provides Business Update
04/30/2025 07:30 AM EDT GlobeNewswire InflaRx to Report First Quarter 2025 Results on May 7, 2025
03/20/2025 07:30 AM EDT GlobeNewswire InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones
03/07/2025 08:00 AM EST GlobeNewswire InflaRx Showcases Vilobelimab's Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
02/28/2025 09:00 AM EST GlobeNewswire InflaRx to Showcase Vilobelimab's Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
02/25/2025 07:30 AM EST GlobeNewswire InflaRx to Report Full Year 2024 Results on March 20 and Announces Participation in March Investor Conferences
02/18/2025 04:01 PM EST GlobeNewswire InflaRx Announces Closing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
02/18/2025 08:00 AM EST ACCESS Newswire Infinitum: Pioneering Quantum-Proof Blockchain Solutions to Transform Finance
Page

Additional News

As of June 7, 2025 • 6:00 AM ET

Date/Time Source News Release
05/29/2025 08:15 AM EDT KlickAnalytics Outperform Recommendation Issued On IFRX By Raymond James
05/28/2025 06:58 AM EDT SeekingAlpha InflaRx plunges on plans to halt studies into lead asset in rare skin disorder
05/07/2025 07:37 AM EDT SeekingAlpha InflaRx GAAP EPS of -Euro0.13
05/07/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Wednesday, May 7th, 2025
05/07/2025 05:31 AM EDT US Earnings Reports Expected earnings - InflaRx N.V.
05/06/2025 09:35 AM EDT Zacks Aligos Therapeutics, Inc. (ALGS) Reports Q1 Loss, Misses Revenue Estimates
04/29/2025 04:45 PM EDT AllPennyStocks.com Biotech Shares Jump As Institutional Coverage Begins With Positive Outlook
03/26/2025 12:15 PM EDT KlickAnalytics Buy Recommendation Issued On IFRX By Guggenheim
03/26/2025 09:35 AM EDT Zacks InflaRx (IFRX) Loses -15.29% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
03/20/2025 07:34 AM EDT SeekingAlpha InflaRx GAAP EPS of -Euro0.78, revenue of Euro0.17M
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.